NF-Kappa-B downregulation strategies in head and neck cancer treatment

Alpen Patel, Lindsay Miller, Khalil Ahmed, Frank Ondrey

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Objective Multiple biochemical and genetic strategies were used to downregulate early response gene NF-κB, whose activation controls squamous cell cancer-associated pathways. Study design NA cells, an oral cavity squamous cell cancer with high NF-κB activity, were cultured with biochemical NF-κB inhibitors TPCK and Calpain I inhibitor, as well as specific NF-κB antisense oligonucleotides. Cell proliferation was measured, as was NF-κB downregulation using functional luciferase reporter genes and electromobility shift assays. Results Significant downregulation of cell proliferation and NF-κB functional activity were demonstrated with either biochemical inhibitor, as well as the antisense oligonucleotides; however, additional nonspecific toxicities were observed with control antisense oligonucleotides. Conclusion and significance NF-κB is a potential target for squamous cancer treatment, as it is constitutively upregulated in vitro. Biochemical inhibition of NF-κB may be a viable treatment strategy for head and neck squamous cancers.

Original languageEnglish (US)
Pages (from-to)288-295
Number of pages8
JournalOtolaryngology - Head and Neck Surgery
Issue number3
StatePublished - Sep 2004

Bibliographical note

Funding Information:
This work was supported by the 5 M University of Minnesota Lions fund and the Department of Otolaryngology at the University of Minnesota. Dr Ahmed is supported by V.A.M.C. Research Funds.

Copyright 2008 Elsevier B.V., All rights reserved.

Fingerprint Dive into the research topics of 'NF-Kappa-B downregulation strategies in head and neck cancer treatment'. Together they form a unique fingerprint.

Cite this